Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Imiquimod - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for imiquimod and what is the scope of freedom to operate?

Imiquimod
is the generic ingredient in three branded drugs marketed by Strides Pharma, Apotex Inc, Medicis, Perrigo Israel, Tolmar, Fougera Pharms, Taro, G And W Labs Inc, and Glenmark Generics, and is included in ten NDAs. There are six patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Imiquimod has twenty patent family members in seventeen countries.

There are thirteen drug master file entries for imiquimod. Eleven suppliers are listed for this compound.

Summary for Generic Name: imiquimod

Tradenames:3
Patents:6
Applicants:9
NDAs:10
Drug Master File Entries: see list13
Suppliers / Packagers: see list11
Bulk Api Vendors: see list86
Clinical Trials: see list41
Patent Applications: see list5,533
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:imiquimod at DailyMed

Pharmacology for Ingredient: imiquimod

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis
ZYCLARA
imiquimod
CREAM;TOPICAL022483-001Mar 25, 2010RXYesYes8,598,196► Subscribe ► Subscribe
Taro
IMIQUIMOD
imiquimod
CREAM;TOPICAL200173-001Apr 15, 2011ABRXNoNo► Subscribe► Subscribe
Medicis
ZYCLARA
imiquimod
CREAM;TOPICAL022483-002Jul 15, 2011RXYesYes8,222,270► Subscribe ► Subscribe
Medicis
ZYCLARA
imiquimod
CREAM;TOPICAL022483-001Mar 25, 2010RXYesYes8,236,816► Subscribe ► Subscribe
Glenmark Generics
IMIQUIMOD
imiquimod
CREAM;TOPICAL201994-001Mar 6, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot